KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹18 Cr | ₹20 Cr | ₹41 Cr | ₹21 Cr | ₹42 Cr |
What is the latest Contingent Liabilities ratio of KOPRAN ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹21 Cr |
Mar2020 | ₹42 Cr |
How is Contingent Liabilities of KOPRAN Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | -9.05 | |
Mar2023 | ₹20 Cr | -51.22 | |
Mar2022 | ₹41 Cr | 93.30 | |
Mar2021 | ₹21 Cr | -49.30 | |
Mar2020 | ₹42 Cr | - |
Compare Contingent Liabilities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,477.8 Cr | 5.4% | 3.7% | 37.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹434,604.0 Cr | 0.1% | -4% | 52.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,639.0 Cr | 0.7% | -0% | 70.9% | Stock Analytics | |
CIPLA | ₹128,549.0 Cr | 0.5% | -1.7% | 29.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,956.0 Cr | 1.1% | -2.6% | 19.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,468.9 Cr | -3.6% | -8.4% | 62.9% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 5.4% |
3.7% |
37.4% |
SENSEX | -0.3% |
-2.4% |
22.4% |
You may also like the below Video Courses